Developmental factors associated with risk for atopic disease: Implications for vaccine strategies in early childhood

Vaccine

Volumn 21, Issue 24, 2003, Pages 3432-3435

  Holt, P G ^a   Rowe, J ^a   Loh, R ^b   Sly, P D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Atopic disease; Developmental factors; Vaccination

Indexed keywords

ALLERGEN; MATERNAL ANTIBODY; VACCINE;

ALLERGY; ATOPY; CELL FUNCTION; CELLULAR IMMUNITY; CONFERENCE PAPER; DISEASE COURSE; DRUG RESPONSE; ENVIRONMENTAL FACTOR; HUMAN; KINETICS; MEMORY CELL; MICROORGANISM; NONHUMAN; ONTOGENY; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT; T LYMPHOCYTE; TH1 CELL; UPREGULATION; VACCINATION;

EID: 0038722316     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00345-1     Document Type: Conference Paper

References (38)

1. Farooqi I.S., Hopkin J.M. Early childhood infection and atopic disorder. Thorax. 53:1998;927-932.
2. Shaheen S.O., Aaby P., Hall A.J.et al. Measles and atopy in Guinea-Bissau. Lancet. 347:1996;1792-1796.
3. Kon O.M., Goyal M., Filley E.et al. Mycobacterium vaccae: a study of safety and outcome measures. Respir. Med. 92:1998;597-598.
4. Wang C.C., Rook G.A. Inhibition of an established response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology. 93:1998;307-313.
5. Paunio M., Heinonen O., Virtanen M., Leinikki P., Patja A., Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. JAMA. 283:2000;343-346.
6. Alm J.S., Lilja G., Pershagen G., Scheynius A. Early BCG vaccination and development of atopy. Lancet. 350:1997;400-403.
7. Strannegård I.-L., Larsson L.-O., Wennergren G., Strannegård O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy. 53:1998;249-254.
8. Strachan D.P. Family size, infection and atopy: the first decease of the hygiene hypothesis. Thorax. 55(Suppl. 1):2000;S2-S10.
9. Johnston S.L., Pattemore P.K., Sanderson G.et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med. 154:1996;654-660.
10. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:1989;145-173.
11. Macaubas C., Sly P.D., Burton P.et al. Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin. Exp. Allergy. 29:1999;1223-1231.
12. Macaubas C., Lee P.T., Smallacombe T.B., Holt B.J., Wee C., Sly P.D.et al. Reciprocal patterns of allergen-induced GATA-3 expression in peripheral blood mononuclear cells from atopics versus non-atopics. Clin. Exp. Allergy. 32:2002;97-106.
13. Prescott S.L., Macaubas C., Smallacombe T., Holt B.J., Sly P.D., Holt P.G. Development of allergen-specific T-cell memory in atopic and normal children. Lancet. 353:1999;196-200.
14. Oddy W.H., Holt P.G., Sly P.D.et al. Association between breast feeding and asthma in 6 year old children: findings from a prospective birth cohort study. BMJ. 319:1999;815-819.
15. Holt P.G., Macaubas C. Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr. Opin. Immunol. 9:1997;782-787.
16. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today. 14:1993;353-356.
17. - T-cells. J. Immunol. 168:2002;2820-2827.
18. Holt P.G. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr. Allergy Immunol. 6:1995;1-10.
19. Rowe J., Macaubas C., Monger T.et al. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J. Infect. Dis. 184:2001;80-88.
20. Holt P.G., Clough J.B., Holt B.J.et al. Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin. Exp. Allergy. 22:1992;1093-1099.
21. Prescott S.L., Sly P.D., Holt P.G. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy. Lancet. 351:1998;1489.
22. Arkwright P.D., Patel L., Moran A., Haeney M.R., Ewing C.I., David T.J. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin. Exp. Immunol. 122:2000;16-19.
23. Shirakawa T., Enomoto T., Shimazu S., Hopkin J.M. Inverse association between tuberculin responses and atopic disorder. Science. 275:1997;77-79.
24. Holt P.G., Sly P.D. Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J. Exp. Med. 196:2002;1271-1275.
25. Culley F.J., Pollott J., Openshaw P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196:2002;1381-1386.
26. Yap G., Pesin M., Sher A. IL-12 is required for the maintenance of IFNγ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:2000;628-631.
27. Goriely S., Vincart B., Stordeur P.et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166:2001;2141-2146.
28. Upham J.W., Lee P.T., Holt B.J.et al. Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 70:2002;6583-6588.
29. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., Martinez F.D. A polymorphism in the 5′-flanking region of the CD14 gene is associated with circulating soluble CD14 levels with total serum IgE. Am. J. Respir. Cell. Mol. Biol. 20:1999;976-983.
30. Lauener R.P., Birchler T., Adamski J.et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet. 360:2002;465-466.
31. Morahan G., Huang D., Wu M.et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet. 360:2002;455-459.
32. Aaby P., Shaheen S.O., Heyes C.B.et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy. 30:2000;644-650.
33. Le Souëf P.N., Goldblatt J., Lynch N.R. Evolutionary adaption of inflammatory immune responses in human beings. Lancet. 356:2000;242-244.
34. Holt P.G., Rudin A., Macaubas C.et al. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J. Allergy Clin. Immunol. 105:2000;1117-1122.
35. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., Thepen T.et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:1998;359-361.
36. Magnan A.O., Mely L.G., Camilla C.A.et al. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am. J. Respir. Crit. Care Med. 161:2000;1790-1796.
37. Smart J.M., Kemp A.S. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin. Exp. Allergy. 32:2002;796-802.
38. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 271:1996;1723-1726.